{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T02:44:45Z","timestamp":1778899485398,"version":"3.51.4"},"reference-count":113,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Kidney Disease and Health"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1053\/j.akdh.2023.12.009","type":"journal-article","created":{"date-parts":[[2024,4,21]],"date-time":"2024-04-21T03:55:53Z","timestamp":1713671753000},"page":"139-146","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Hyponatremia in the Context of Liver Disease"],"prefix":"10.1053","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5562-8899","authenticated-orcid":false,"given":"Amy A.","family":"Yau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4437-6862","authenticated-orcid":false,"given":"Florian","family":"Buchkremer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10 Suppl 1","key":"10.1053\/j.akdh.2023.12.009_bib1","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.amjmed.2013.07.006","article-title":"Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations","volume":"126","author":"Verbalis","year":"2013","journal-title":"Am J Med"},{"issue":"Suppl 2","key":"10.1053\/j.akdh.2023.12.009_bib2","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1093\/ndt\/gfu040","article-title":"Clinical practice guideline on diagnosis and treatment of hyponatraemia","volume":"29","author":"Spasovski","year":"2014","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1053\/j.akdh.2023.12.009_bib3","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/BF01095898","article-title":"Prognostic value of spontaneous hyponatremia in cirrhosis with ascites","volume":"21","author":"Arroyo","year":"1976","journal-title":"Am J Dig Dis"},{"issue":"6","key":"10.1053\/j.akdh.2023.12.009_bib4","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/0016-5085(85)90664-X","article-title":"Derangements of renal water handling in liver disease","volume":"89","author":"Epstein","year":"1985","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1053\/j.akdh.2023.12.009_bib5","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S1590-8658(00)80844-0","article-title":"Clinical relevance of hyponatraemia for the hospital outcome of cirrhotic patients","volume":"32","author":"Borroni","year":"2000","journal-title":"Dig Liver Dis"},{"issue":"6","key":"10.1053\/j.akdh.2023.12.009_bib6","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1002\/hep.21412","article-title":"Hyponatremia in cirrhosis: results of a patient population survey","volume":"44","author":"Angeli","year":"2006","journal-title":"Hepatology"},{"issue":"1","key":"10.1053\/j.akdh.2023.12.009_bib7","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.dld.2019.08.013","article-title":"Combination and sequential evaluation of acute-on-chronic liver failure (ACLF) and hyponatremia and prognosis in cirrhotic patients","volume":"52","author":"Pereira","year":"2020","journal-title":"Dig Liver Dis"},{"issue":"1","key":"10.1053\/j.akdh.2023.12.009_bib8","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s12072-021-10282-8","article-title":"Prevalence and clinical significance of serum sodium variability in patients with acute-on-chronic liver diseases: a prospective multicenter study in China","volume":"16","author":"Mei","year":"2022","journal-title":"Hepatol Int"},{"issue":"5","key":"10.1053\/j.akdh.2023.12.009_bib9","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.jhep.2016.12.003","article-title":"EASL Clinical practical guidelines on the management of acute (fulminant) liver failure","volume":"66","author":"Wendon","year":"2017","journal-title":"J Hepatol"},{"issue":"10","key":"10.1053\/j.akdh.2023.12.009_bib10","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMoa0801209","article-title":"Hyponatremia and mortality among patients on the liver-transplant waiting list","volume":"359","author":"Kim","year":"2008","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1053\/j.akdh.2023.12.009_bib11","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1002\/lt.25327","article-title":"Hyponatremia in cirrhosis: implications for liver transplantation","volume":"24","author":"Leise","year":"2018","journal-title":"Liver Transpl"},{"issue":"11","key":"10.1053\/j.akdh.2023.12.009_bib12","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.14309\/ajg.0000000000000786","article-title":"Hyponatremia in cirrhosis: an update","volume":"115","author":"Alukal","year":"2020","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1053\/j.akdh.2023.12.009_bib13","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.cld.2022.01.001","article-title":"Hyponatremia in cirrhosis","volume":"26","author":"Rondon-Berrios","year":"2022","journal-title":"Clin Liver Dis"},{"issue":"1","key":"10.1053\/j.akdh.2023.12.009_bib14","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jhep.2020.08.009","article-title":"Endpoints and design of clinical trials in patients with decompensated cirrhosis: position paper of the LiverHope Consortium","volume":"74","author":"Sol\u00e0","year":"2021","journal-title":"J Hepatol"},{"issue":"6","key":"10.1053\/j.akdh.2023.12.009_bib15","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.jhep.2012.07.020","article-title":"Factors related to quality of life in patients with cirrhosis and ascites: relevance of serum sodium concentration and leg edema","volume":"57","author":"Sol\u00e0","year":"2012","journal-title":"J Hepatol"},{"issue":"3","key":"10.1053\/j.akdh.2023.12.009_bib16","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.jhep.2013.04.023","article-title":"Differential impact of hyponatremia and hepatic encephalopathy on health-related quality of life and brain metabolite abnormalities in cirrhosis","volume":"59","author":"Ahluwalia","year":"2013","journal-title":"J Hepatol"},{"issue":"4","key":"10.1053\/j.akdh.2023.12.009_bib17","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/hep.1840400409","article-title":"Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death","volume":"40","author":"Heuman","year":"2004","journal-title":"Hepatology"},{"issue":"6","key":"10.1053\/j.akdh.2023.12.009_bib18","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1186\/s13054-014-0700-0","article-title":"Hyponatremia influences the outcome of patients with acute-on-chronic liver failure: an analysis of the CANONIC study","volume":"18","author":"C\u00e1rdenas","year":"2014","journal-title":"Crit Care"},{"issue":"7","key":"10.1053\/j.akdh.2023.12.009_bib19","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1053\/j.gastro.2011.02.017","article-title":"A revised model for end-stage liver disease optimizes prediction of mortality among patients awaiting liver transplantation","volume":"140","author":"Leise","year":"2011","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1053\/j.akdh.2023.12.009_bib20","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1053\/j.gastro.2018.07.025","article-title":"Effects of allocating livers for transplantation based on model for end-stage liver disease-sodium scores on patient outcomes","volume":"155","author":"Nagai","year":"2018","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1053\/j.akdh.2023.12.009_bib21","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1053\/j.jvca.2021.05.027","article-title":"Hyponatremia and liver transplantation: a Narrative review","volume":"36","author":"Verbeek","year":"2021","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"8","key":"10.1053\/j.akdh.2023.12.009_bib22","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1002\/lt.21154","article-title":"The impact of serum sodium concentration on mortality after liver transplantation: a cohort multicenter study","volume":"13","author":"Dawwas","year":"2007","journal-title":"Liver Transpl"},{"issue":"6","key":"10.1053\/j.akdh.2023.12.009_bib23","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/lt.23860","article-title":"Effect of the pretransplant serum sodium concentration on outcomes following liver transplantation","volume":"20","author":"Leise","year":"2014","journal-title":"Liver Transpl"},{"issue":"12","key":"10.1053\/j.akdh.2023.12.009_bib24","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1111\/tri.14123","article-title":"Extreme hyponatremia as a risk factor for early mortality after liver transplantation in the MELD-sodium era","volume":"34","author":"Ivanics","year":"2021","journal-title":"Transpl Int"},{"issue":"1","key":"10.1053\/j.akdh.2023.12.009_bib25","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-37006-7","article-title":"Intraoperative hyponatremia is an independent predictor of one-year mortality after liver transplantation","volume":"8","author":"Yang","year":"2018","journal-title":"Sci Rep"},{"issue":"6","key":"10.1053\/j.akdh.2023.12.009_bib26","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1038\/ajg.2009.293","article-title":"Hyponatremia is a risk factor of hepatic encephalopathy in patients with cirrhosis: a prospective study with time-dependent analysis","volume":"104","author":"Guevara","year":"2009","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"10.1053\/j.akdh.2023.12.009_bib27","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1111\/j.1478-3231.2010.02293.x","article-title":"Risk factors for hepatic encephalopathy in patients with cirrhosis and refractory ascites: relevance of serum sodium concentration","volume":"30","author":"Guevara","year":"2010","journal-title":"Liver Int"},{"issue":"9","key":"10.1053\/j.akdh.2023.12.009_bib28","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1172\/JCI103712","article-title":"Interrelations between serum sodium concentration, serum osmolarity and total exchangeable sodium, total exchangeable potassium and total body water","volume":"37","author":"EDELMAN","year":"1958","journal-title":"J Clin Invest"},{"key":"10.1053\/j.akdh.2023.12.009_bib29","author":"Buchkremer"},{"issue":"12","key":"10.1053\/j.akdh.2023.12.009_bib30","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1016\/j.ekir.2023.09.002","article-title":"Classifying hypotonic hyponatremia by projected treatment effects-a quantitative, three-dimensional framework","volume":"8","author":"Buchkremer","year":"2023","journal-title":"Kidney Int Reports"},{"issue":"4","key":"10.1053\/j.akdh.2023.12.009_bib31","doi-asserted-by":"crossref","first-page":"413","DOI":"10.7326\/0003-4819-96-4-413","article-title":"Role of vasopressin in abnormal water excretion in cirrhotic patients","volume":"96","author":"Bichet","year":"1982","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1053\/j.akdh.2023.12.009_bib32","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/hep.510280337","article-title":"Hyponatremia in cirrhosis: from pathogenesis to treatment","volume":"28","author":"Gin\u00e9s","year":"1998","journal-title":"Hepatology"},{"issue":"6","key":"10.1053\/j.akdh.2023.12.009_bib33","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/ki.1983.229","article-title":"Mechanisms of improvement of water and sodium excretion by immersion in decompensated cirrhotic patients","volume":"24","author":"Bichet","year":"1983","journal-title":"Kidney Int"},{"issue":"2","key":"10.1053\/j.akdh.2023.12.009_bib34","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/ki.1985.142","article-title":"Interrelationship between cardiac output and vascular resistance as determinants of effective arterial blood volume in cirrhotic patients","volume":"28","author":"Shapiro","year":"1985","journal-title":"Kidney Int"},{"issue":"5","key":"10.1053\/j.akdh.2023.12.009_bib35","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/hep.1840080532","article-title":"Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis","volume":"8","author":"Schrier","year":"1988","journal-title":"Hepatology"},{"issue":"4","key":"10.1053\/j.akdh.2023.12.009_bib36","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/cld.790","article-title":"Approach to hyponatremia in cirrhosis","volume":"13","author":"Attar","year":"2019","journal-title":"Clin Liver Dis"},{"issue":"8","key":"10.1053\/j.akdh.2023.12.009_bib37","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1007\/s10620-017-4597-8","article-title":"Electrolyte and Acid-Base Disturbances in end-stage liver disease: a Physiopathological approach","volume":"62","author":"Jim\u00e9nez","year":"2017","journal-title":"Dig Dis Sci"},{"issue":"5","key":"10.1053\/j.akdh.2023.12.009_bib38","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1007\/s12072-016-9746-1","article-title":"Hyponatremia in patients with liver diseases: not just a cirrhosis-induced hemodynamic compromise","volume":"10","author":"Liamis","year":"2016","journal-title":"Hepatol Int"},{"issue":"2","key":"10.1053\/j.akdh.2023.12.009_bib39","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/hep.31884","article-title":"Diagnosis, evaluation, and management of ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: 2021 practice guidance by the American association for the study of liver diseases","volume":"74","author":"Biggins","year":"2021","journal-title":"Hepatology"},{"issue":"1","key":"10.1053\/j.akdh.2023.12.009_bib40","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/gutjnl-2020-321790","article-title":"Guidelines on the management of ascites in cirrhosis","volume":"70","author":"Aithal","year":"2021","journal-title":"Gut"},{"issue":"10","key":"10.1053\/j.akdh.2023.12.009_bib41","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.3390\/nu11102462","article-title":"The analysis of Food intake in patients with cirrhosis waiting for liver transplantation: a neglected step in the nutritional assessment","volume":"11","author":"Palmese","year":"2019","journal-title":"Nutrients"},{"issue":"6","key":"10.1053\/j.akdh.2023.12.009_bib42","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1681\/ASN.2007091042","article-title":"Impact of solute intake on urine flow and water excretion","volume":"19","author":"Berl","year":"2008","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.akdh.2023.12.009_bib43","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1159\/000184016","article-title":"Treatment of hyponatremic cirrhosis with ascites resistant to diuretics by urea","volume":"44","author":"Decaux","year":"1986","journal-title":"Nephron"},{"issue":"5","key":"10.1053\/j.akdh.2023.12.009_bib44","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1053\/j.ackd.2015.02.002","article-title":"Hyponatremia in cirrhosis--pathogenesis, treatment, and Prognostic significance","volume":"22","author":"Sinha","year":"2015","journal-title":"Adv Chronic Kidney Dis"},{"issue":"2","key":"10.1053\/j.akdh.2023.12.009_bib45","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","article-title":"EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis","volume":"69","author":"Angeli","year":"2018","journal-title":"J Hepatol"},{"issue":"2","key":"10.1053\/j.akdh.2023.12.009_bib46","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1053\/j.ajkd.2019.07.014","article-title":"Diagnosis and management of disorders of body tonicity-hyponatremia and Hypernatremia: Core Curriculum 2020","volume":"75","author":"Seay","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.akdh.2023.12.009_bib47","author":"Buchkremer"},{"issue":"1","key":"10.1053\/j.akdh.2023.12.009_bib48","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/sj.bmt.1704739","article-title":"Severe hypercholesterolemia mediated by lipoprotein X in patients with chronic graft-versus-host disease of the liver","volume":"35","author":"Turchin","year":"2005","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1053\/j.akdh.2023.12.009_bib49","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/MAJ.0b013e3182703327","article-title":"Pseudohyponatremia in acute liver disease","volume":"345","author":"Vo","year":"2013","journal-title":"Am J Med Sci"},{"issue":"2","key":"10.1053\/j.akdh.2023.12.009_bib50","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jacl.2014.11.007","article-title":"Extreme hypercholesterolemia presenting with pseudohyponatremia - a case report and review of the literature","volume":"9","author":"Hussain","year":"2015","journal-title":"J Clin Lipidol"},{"key":"10.1053\/j.akdh.2023.12.009_bib51","article-title":"Pseudohyponatraemia secondary to hyperlipidaemia in obstructive jaundice","volume":"2017","author":"Igbinedion","year":"2017","journal-title":"BMJ Case Rep"},{"issue":"2","key":"10.1053\/j.akdh.2023.12.009_bib52","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s11938-001-0022-6","article-title":"Hyperlipidemia in chronic cholestatic liver disease","volume":"4","author":"Longo","year":"2001","journal-title":"Curr Treat Options Gastroenterol"},{"issue":"4","key":"10.1053\/j.akdh.2023.12.009_bib53","doi-asserted-by":"crossref","first-page":"516","DOI":"10.5858\/2010-0018-RS.1","article-title":"Pseudohyponatremia revisited: a modern-day pitfall","volume":"135","author":"Fortgens","year":"2011","journal-title":"Arch Pathol Lab Med"},{"issue":"4","key":"10.1053\/j.akdh.2023.12.009_bib54","doi-asserted-by":"crossref","first-page":"835","DOI":"10.14309\/ajg.0000000000001011","article-title":"Measuring serum sodium in cirrhosis: Regarding \u201chyponatremia in cirrhosis: an update\u201d","volume":"116","author":"Morton","year":"2021","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1053\/j.akdh.2023.12.009_bib55","doi-asserted-by":"crossref","first-page":"835","DOI":"10.14309\/ajg.0000000000001047","article-title":"Reply to Morton","volume":"116","author":"Alukal","year":"2021","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1053\/j.akdh.2023.12.009_bib56","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s11011-010-9172-3","article-title":"Hyponatremic and hepatic encephalopathies: similarities, differences and coexistence","volume":"25","author":"C\u00f3rdoba","year":"2010","journal-title":"Metab Brain Dis"},{"issue":"9","key":"10.1053\/j.akdh.2023.12.009_bib57","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1515\/hsz-2021-0168","article-title":"Pathomechanisms in hepatic encephalopathy","volume":"402","author":"H\u00e4ussinger","year":"2021","journal-title":"Biol Chem"},{"issue":"3","key":"10.1053\/j.akdh.2023.12.009_bib58","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/cen.13243","article-title":"Evaluation of copeptin and commonly used laboratory parameters for the differential diagnosis of profound hyponatraemia in hospitalized patients: \u2018The Co-MED Study\u2019","volume":"86","author":"Nigro","year":"2017","journal-title":"Clin Endocrinol"},{"issue":"5","key":"10.1053\/j.akdh.2023.12.009_bib59","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.ekir.2021.02.003","article-title":"Use of urine electrolytes and urine osmolality in the clinical diagnosis of fluid, electrolytes, and Acid-Base disorders","volume":"6","author":"Kamel","year":"2021","journal-title":"Kidney Int Rep"},{"issue":"3","key":"10.1053\/j.akdh.2023.12.009_bib60","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1159\/000501299","article-title":"Point-of-Care Echocardiography Unveils Misclassification of acute kidney injury as hepatorenal syndrome","volume":"50","author":"Velez","year":"2019","journal-title":"Am J Nephrol"},{"issue":"6","key":"10.1053\/j.akdh.2023.12.009_bib61","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2020-235304","article-title":"Point-of-care ultrasound to evaluate volume status in severe hyponatremia","volume":"13","author":"Evins","year":"2020","journal-title":"BMJ Case Rep"},{"issue":"8","key":"10.1053\/j.akdh.2023.12.009_bib62","doi-asserted-by":"crossref","DOI":"10.1002\/ccr3.4687","article-title":"Point-of-care Doppler ultrasound in the management of hyponatremia: another string to nephrologists\u2019 Bow","volume":"9","author":"Samant","year":"2021","journal-title":"Clin Case Rep"},{"key":"10.1053\/j.akdh.2023.12.009_bib63","article-title":"The Use of portal Vein Pulsatility to Differentiate Hypervolemic and Hypovolemic hyponatremia","volume":"2019","author":"Singh","year":"2019","journal-title":"Case Rep Crit Care"},{"issue":"1","key":"10.1053\/j.akdh.2023.12.009_bib64","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s13730-021-00623-9","article-title":"Point of care cardiac ultrasound in the management of hyponatremia: an enhancement to physical examination","volume":"11","author":"Chatterjee","year":"2022","journal-title":"CEN Case Rep"},{"issue":"2","key":"10.1053\/j.akdh.2023.12.009_bib65","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2021-246995","article-title":"Use of Venous Excess UltraSound (VExUS) score in hyponatraemia management in critically ill patient","volume":"15","author":"Varudo","year":"2022","journal-title":"BMJ Case Rep"},{"issue":"1","key":"10.1053\/j.akdh.2023.12.009_bib66","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jhep.2014.09.028","article-title":"Correction of hyponatraemia in cirrhosis: treating more than a number","volume":"62","author":"C\u00e1rdenas","year":"2015","journal-title":"J Hepatol"},{"key":"10.1053\/j.akdh.2023.12.009_bib67","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.729545","article-title":"Hyponatremia intervention trial (HIT): study protocol of a randomized, controlled, parallel-group trial with blinded outcome assessment","volume":"8","author":"Refardt","year":"2021","journal-title":"Front Med"},{"issue":"3","key":"10.1053\/j.akdh.2023.12.009_bib68","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jhep.2010.05.004","article-title":"EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis","volume":"53","author":"Gin\u00e8s","year":"2010","journal-title":"J Hepatol"},{"key":"10.1053\/j.akdh.2023.12.009_bib69","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/1579508","article-title":"Management Strategies and outcomes for hyponatremia in cirrhosis in the hyponatremia Registry","volume":"2018","author":"Sigal","year":"2018","journal-title":"Can J Gastroenterol Hepatol"},{"issue":"7179","key":"10.1053\/j.akdh.2023.12.009_bib70","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0140-6736(61)91719-6","article-title":"Exchangeable potassium in wasting, amyotrophy, heart-disease, and cirrhosis of the liver","volume":"1","author":"NAGANT DE DEUXCHAISNES","year":"1961","journal-title":"Lancet"},{"key":"10.1053\/j.akdh.2023.12.009_bib71","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0016-5085(65)80138-X","article-title":"Body and serum potassium IN liver disease. I. Relationship to hepatic function and associated factors","volume":"48","author":"CASEY","year":"1965","journal-title":"Gastroenterology"},{"key":"10.1053\/j.akdh.2023.12.009_bib72","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0016-5085(65)80139-1","article-title":"Body and serum potassium in liver disease. II. Relationships to arterial ammonia, blood PH, and hepatic coma","volume":"48","author":"CASEY","year":"1965","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1053\/j.akdh.2023.12.009_bib73","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/0002-9343(94)90166-X","article-title":"Osmotic demyelination syndrome following correction of hyponatremia: association with hypokalemia","volume":"96","author":"Lohr","year":"1994","journal-title":"Am J Med"},{"issue":"7","key":"10.1053\/j.akdh.2023.12.009_bib74","doi-asserted-by":"crossref","first-page":"984","DOI":"10.2215\/CJN.13061117","article-title":"Risk factors and outcomes of rapid correction of severe hyponatremia","volume":"13","author":"George","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.akdh.2023.12.009_bib75","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1053\/j.ajkd.2021.07.020","article-title":"Hypertonic saline for hyponatremia: Meeting Goals and avoiding Harm","volume":"79","author":"Rondon-Berrios","year":"2022","journal-title":"Am J Kidney Dis"},{"issue":"10","key":"10.1053\/j.akdh.2023.12.009_bib76","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1111\/ajt.14317","article-title":"Prevention of the osmotic demyelination syndrome after liver transplantation: a Multidisciplinary Perspective","volume":"17","author":"Crismale","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1053\/j.akdh.2023.12.009_bib77","article-title":"Albumin in the management of hepatic encephalopathy: a systematic review and meta-analysis","volume":"26","author":"Is","year":"2021","journal-title":"Ann Hepatol"},{"issue":"9","key":"10.1053\/j.akdh.2023.12.009_bib78","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/s41395-018-0119-3","article-title":"The impact of albumin Use on resolution of hyponatremia in hospitalized patients with cirrhosis","volume":"113","author":"Bajaj","year":"2018","journal-title":"Am J Gastroenterol"},{"issue":"10138","key":"10.1053\/j.akdh.2023.12.009_bib79","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1016\/S0140-6736(18)30840-7","article-title":"Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial","volume":"391","author":"Caraceni","year":"2018","journal-title":"Lancet"},{"issue":"11","key":"10.1053\/j.akdh.2023.12.009_bib80","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.14309\/ajg.0000000000001488","article-title":"Targeted albumin therapy Does not improve short-term outcome in hyponatremic patients hospitalized with complications of cirrhosis: Data from the ATTIRE trial","volume":"116","author":"China","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.akdh.2023.12.009_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2021.100547","article-title":"Safety and efficacy of human serum albumin treatment in patients with cirrhotic ascites undergoing paracentesis: a systematic review and meta-analysis","volume":"26","author":"Shrestha","year":"2021","journal-title":"Ann Hepatol"},{"issue":"2","key":"10.1053\/j.akdh.2023.12.009_bib82","doi-asserted-by":"crossref","first-page":"G229","DOI":"10.1152\/ajpgi.00424.2013","article-title":"Defining the role of albumin infusion in cirrhosis-associated hyponatremia","volume":"307","author":"Nguyen","year":"2014","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"19","key":"10.1053\/j.akdh.2023.12.009_bib83","doi-asserted-by":"crossref","first-page":"5928","DOI":"10.3390\/jcm11195928","article-title":"Use of human albumin administration for the Prevention and treatment of hyponatremia in patients with liver cirrhosis: a systematic review and meta-analysis","volume":"11","author":"Bai","year":"2022","journal-title":"J Clin Med"},{"issue":"5","key":"10.1053\/j.akdh.2023.12.009_bib84","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14276","article-title":"A protocol for the management of hyponatremia peri-liver transplant reduces post-transplant neurological complications","volume":"35","author":"Crismale","year":"2021","journal-title":"Clin Transplant"},{"issue":"2","key":"10.1053\/j.akdh.2023.12.009_bib85","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1002\/hep.24519","article-title":"Terlipressin: an asset for hepatologists","volume":"54","author":"Sarin","year":"2011","journal-title":"Hepatology"},{"issue":"5","key":"10.1053\/j.akdh.2023.12.009_bib86","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1002\/hep.23893","article-title":"Hyponatremia in patients treated with terlipressin for severe gastrointestinal bleeding due to portal hypertension","volume":"52","author":"Sol\u00e0","year":"2010","journal-title":"Hepatology"},{"issue":"3","key":"10.1053\/j.akdh.2023.12.009_bib87","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/jgh3.12254","article-title":"A retrospective analysis of hyponatremia during terlipressin treatment in patients with esophageal or gastric variceal bleeding due to portal hypertension","volume":"4","author":"Han","year":"2020","journal-title":"JGH Open"},{"issue":"7","key":"10.1053\/j.akdh.2023.12.009_bib88","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1080\/00365521.2020.1786851","article-title":"A study on clinical outcomes of combination of terlipressin and albumin in Hepatorenal Syndrome","volume":"55","author":"Krishna","year":"2020","journal-title":"Scand J Gastroenterol"},{"issue":"9","key":"10.1053\/j.akdh.2023.12.009_bib89","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJMoa2008290","article-title":"Terlipressin plus albumin for the treatment of type 1 hepatorenal syndrome","volume":"384","author":"Wong","year":"2021","journal-title":"N Engl J Med"},{"issue":"10S","key":"10.1053\/j.akdh.2023.12.009_bib90","doi-asserted-by":"crossref","first-page":"e877","DOI":"10.14309\/01.ajg.0000861468.93025.b8","article-title":"S1207 impact of terlipressin on serum sodium levels in patients with hepatorenal syndrome type 1 (HRS-1): CONFIRM study","volume":"117","author":"Pyrsopoulos","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.akdh.2023.12.009_bib91","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3389\/fmed.2017.00017","article-title":"Treatment of cirrhosis-associated hyponatremia with midodrine and octreotide","volume":"4","author":"Patel","year":"2017","journal-title":"Front Med"},{"issue":"2","key":"10.1053\/j.akdh.2023.12.009_bib92","first-page":"315","article-title":"Conivaptan: a step forward in the treatment of hyponatremia","volume":"4","author":"Hline","year":"2008","journal-title":"Ther Clin Risk Manag"},{"issue":"12","key":"10.1053\/j.akdh.2023.12.009_bib93","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1038\/sj.ki.5000432","article-title":"Vasopressin receptor antagonists","volume":"69","author":"Greenberg","year":"2006","journal-title":"Kidney Int"},{"issue":"20","key":"10.1053\/j.akdh.2023.12.009_bib94","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1056\/NEJMoa065181","article-title":"Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia","volume":"355","author":"Schrier","year":"2006","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1053\/j.akdh.2023.12.009_bib95","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jhep.2011.08.020","article-title":"Tolvaptan, an oral vasopressin antagonist, in the treatment of hyponatremia in cirrhosis","volume":"56","author":"C\u00e1rdenas","year":"2012","journal-title":"J Hepatol"},{"issue":"1","key":"10.1053\/j.akdh.2023.12.009_bib96","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s12876-018-0857-0","article-title":"Tolvaptan treatment improves survival of cirrhotic patients with ascites and hyponatremia","volume":"18","author":"Wang","year":"2018","journal-title":"BMC Gastroenterol"},{"issue":"1","key":"10.1053\/j.akdh.2023.12.009_bib97","doi-asserted-by":"crossref","first-page":"123","DOI":"10.5604\/16652681.1226823","article-title":"Utility and safety of tolvaptan in cirrhotic patients with hyponatremia: a prospective cohort study","volume":"16","author":"Jia","year":"2017","journal-title":"Ann Hepatol"},{"issue":"4","key":"10.1053\/j.akdh.2023.12.009_bib99","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1681\/ASN.2009080857","article-title":"Oral tolvaptan is safe and effective in chronic hyponatremia","volume":"21","author":"Berl","year":"2010","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"10.1053\/j.akdh.2023.12.009_bib100","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1007\/s00535-020-01691-x","article-title":"Real-world effectiveness and safety of tolvaptan in liver cirrhosis patients with hepatic edema: results from a post-marketing surveillance study (START study)","volume":"55","author":"Sakaida","year":"2020","journal-title":"J Gastroenterol"},{"issue":"25","key":"10.1053\/j.akdh.2023.12.009_bib101","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","article-title":"Tolvaptan in patients with autosomal dominant polycystic kidney disease","volume":"367","author":"Torres","year":"2012","journal-title":"N Engl J Med"},{"issue":"1-2","key":"10.1053\/j.akdh.2023.12.009_bib102","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1159\/000503773","article-title":"Urea for chronic hyponatremia","volume":"49","author":"Rondon-Berrios","year":"2020","journal-title":"Blood Purif"},{"issue":"3","key":"10.1053\/j.akdh.2023.12.009_bib103","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1681\/ASN.2019090944","article-title":"A randomized trial of Empagliflozin to increase plasma sodium levels in patients with the syndrome of inappropriate antidiuresis","volume":"31","author":"Refardt","year":"2020","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.akdh.2023.12.009_bib104","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/ejendo\/lvad108","article-title":"Effect of protein supplementation on plasma sodium levels in the syndrome of inappropriate antidiuresis: a monocentric, open-label, proof-of-concept study-the TREASURE study","volume":"189","author":"Monnerat","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"6484","key":"10.1053\/j.akdh.2023.12.009_bib105","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1136\/bmj.290.6484.1782","article-title":"Use of urea for treatment of water retention in hyponatraemic cirrhosis with ascites resistant to diuretics","volume":"290","author":"Decaux","year":"1985","journal-title":"Br Med J"},{"issue":"7","key":"10.1053\/j.akdh.2023.12.009_bib106","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1056\/NEJM195208142470703","article-title":"The syndrome of impending hepatic coma in patients with cirrhosis of the liver given certain nitrogenous substances","volume":"247","author":"Phillips","year":"1952","journal-title":"N Engl J Med"},{"key":"10.1053\/j.akdh.2023.12.009_bib107","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1159\/000493243","article-title":"Adverse Consequences of Overly-rapid correction of hyponatremia","volume":"52","author":"Sterns","year":"2019","journal-title":"Front Horm Res"},{"issue":"1","key":"10.1053\/j.akdh.2023.12.009_bib108","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1034\/j.1399-0012.2000.140101.x","article-title":"Central nervous system complications in liver transplant recipients--incidence, timing, and long-term follow-up","volume":"14","author":"Bronster","year":"2000","journal-title":"Clin Transplant"},{"issue":"1","key":"10.1053\/j.akdh.2023.12.009_bib109","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1053\/j.ajkd.2018.05.017","article-title":"Monitoring urine flow to prevent Overcorrection of hyponatremia: derivation of a safe upper limit based on the Edelman equation","volume":"73","author":"Buchkremer","year":"2019","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1053\/j.akdh.2023.12.009_bib110","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1053\/j.ajkd.2019.07.011","article-title":"Thiazide-associated hyponatremia: clinical Manifestations and Pathophysiology","volume":"75","author":"Filippone","year":"2020","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"10.1053\/j.akdh.2023.12.009_bib111","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.34067\/KID.0004402021","article-title":"Osmotic demyelination syndrome following correction of hyponatremia by \u226410 mEq\/L per Day","volume":"2","author":"Tandukar","year":"2021","journal-title":"Kidney360"},{"issue":"6","key":"10.1053\/j.akdh.2023.12.009_bib112","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1159\/000242426","article-title":"Risk factors for central pontine and extrapontine myelinolysis following orthotopic liver transplantation","volume":"62","author":"Lee","year":"2009","journal-title":"Eur Neurol"},{"issue":"7","key":"10.1053\/j.akdh.2023.12.009_bib113","doi-asserted-by":"crossref","first-page":"756","DOI":"10.23736\/S0375-9393.20.14120-8","article-title":"Osmotic demyelination syndrome: are patients with end-stage liver disease a special risk group","volume":"86","author":"Verbeek","year":"2020","journal-title":"Minerva Anestesiol"},{"issue":"2","key":"10.1053\/j.akdh.2023.12.009_bib114","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/lt.24982","article-title":"Novel intraoperative management in the model for end-stage liver disease-sodium era: continuous venovenous hemofiltration for severe hyponatremia in liver transplantation","volume":"24","author":"Nagai","year":"2018","journal-title":"Liver Transpl"}],"container-title":["Advances in Kidney Disease and Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949813923001337?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949813923001337?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,21]],"date-time":"2024-04-21T05:31:36Z","timestamp":1713677496000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949813923001337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":113,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S2949813923001337"],"URL":"https:\/\/doi.org\/10.1053\/j.akdh.2023.12.009","relation":{},"ISSN":["2949-8139"],"issn-type":[{"value":"2949-8139","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyponatremia in the Context of Liver Disease","name":"articletitle","label":"Article Title"},{"value":"Advances in Kidney Disease and Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.akdh.2023.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the National Kidney Foundation, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}